Nkarta(NKTX)2021-05-14 04:21
$Nkarta(NKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-027569 Act: 34 Size: 206 KB 网页链接查看全文
Nkarta(NKTX)2022-08-18 04:21
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-028981 Size: 11 KB 网页链接查看全文
Nkarta(NKTX)2022-08-12 04:18
$Nkarta(NKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-016868 Act: 34 Size: 410 KB 网页链接查看全文
Nkarta(NKTX)2022-08-12 04:27
$Nkarta(NKTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-016892 Act: 34 Size: 8 MB 网页链接查看全文
Nkarta(NKTX)2022-08-18 04:27
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-028991 Size: 9 KB 网页链接查看全文
Nkarta(NKTX)2022-08-18 04:27
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-028988 Size: 9 KB 网页链接查看全文
蹊之美股生物医药2021-04-05 19:45
作者:Sunny
微信公众号:蹊之美股生物医药 / CaesarBiotech
美国生命科学专业媒体Fierce Biotech公布了2020年生物科技的前10大IPO,具体情况如下:
1 AbCellera Biologics, Inc (ABCL)
标的公司:AbCellera Biologics, Inc (NASDAQ:ABCL)
交易规模: $483 million
...查看全文
Nkarta(NKTX)05-12 04:27
$Nkarta(NKTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-021277 Act: 34 Size: 8 MB 网页链接查看全文
Nkarta(NKTX)05-12 04:12
$Nkarta(NKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-021218 Act: 34 Size: 376 KB 网页链接查看全文
Nkarta(NKTX)05-11 00:33
$Nkarta(NKTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-23-000075 Act: 34 Size: 4 KB 网页链接查看全文
Nkarta(NKTX)05-08 18:06
$Nkarta(NKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001318 Act: 33 Size: 1 KB 网页链接查看全文
Nkarta(NKTX)04-25 05:27
$Nkarta(NKTX)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001140361-23-019944 Act: 33 Size: 443 KB 网页链接查看全文
Nkarta(NKTX)04-25 04:33
$Nkarta(NKTX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-23-019898 Act: 34 Size: 3 MB 网页链接查看全文
Nkarta(NKTX)04-25 04:27
$Nkarta(NKTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-23-019896 Act: 34 Size: 921 KB 网页链接查看全文
Nkarta(NKTX)04-25 04:21
$Nkarta(NKTX)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-23-019890 Act: 34 Size: 1 MB 网页链接查看全文
Nkarta(NKTX)04-15 05:06
$Nkarta(NKTX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-23-018495 Act: 34 Size: 1 MB 网页链接查看全文
Nkarta(NKTX)03-31 04:18
$Nkarta(NKTX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000950170-23-010937 Act: 34 Size: 225 KB 网页链接查看全文
$Nkarta(NKTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-021277 Act: 34 Size: 8 MB 网页链接
$Nkarta(NKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-021218 Act: 34 Size: 376 KB 网页链接
$Nkarta(NKTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-23-000075 Act: 34 Size: 4 KB 网页链接
$Nkarta(NKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001318 Act: 33 Size: 1 KB 网页链接
$Nkarta(NKTX)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001140361-23-019944 Act: 33 Size: 443 KB 网页链接
$Nkarta(NKTX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-23-019898 Act: 34 Size: 3 MB 网页链接
$Nkarta(NKTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-23-019896 Act: 34 Size: 921 KB 网页链接
$Nkarta(NKTX)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-23-019890 Act: 34 Size: 1 MB 网页链接
$Nkarta(NKTX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-23-018495 Act: 34 Size: 1 MB 网页链接
$Nkarta(NKTX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000950170-23-010937 Act: 34 Size: 225 KB 网页链接